Human granulocyte colony stimulating factor (hG-CSF): Cloning, overexpression, purification and characterization

Microbial Cell Factories

Volumn 7, Issue , 2008, Pages

  Vanz, Ana L S ^a,b   Renard, Gaby ^b   Palma, Mario S ^c   Chies, Jocelei M ^b   Dalmora, Sérgio L ^d   Basso, Luiz A ^a   Santos, Diógenes S ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Quatro G Pesquisa e Desenvolvimento LTDA   (Brazil)

^c SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^d FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLOGICAL ACTIVITY; BIOTECHNOLOGICAL PRODUCTION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DNA SEQUENCE; DOSE RESPONSE; DRUG POTENCY; GENETIC CODE; IMMUNOASSAY; MALE; MOLECULAR CLONING; MOUSE; NEUTROPENIA; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYSICAL CHEMISTRY; PROTEIN ENGINEERING; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEIN PURIFICATION; REVERSED PHASE LIQUID CHROMATOGRAPHY;

ESCHERICHIA COLI;

EID: 42649095679     PISSN: None     EISSN: 14752859     Source Type: Journal    
DOI: 10.1186/1475-2859-7-13     Document Type: Article

References (47)

1. EMEA Guideline EMEA/CHMP/BWP/49348/2005 Guideline on similar biological medicinal products containing biotechnology-derived proteins as active substance: Quality issues http://www.emea.europa.eu
2. Riche M: Opportunities for UK Companies in Biopharmaceuticals and Biotechnology in Brazil UK Trade and Investment 2006 http://www.uktradeinvest.gov.uk/ukti/biotechnology
3. Pisani J Bonduelle Y: Opportunities and barriers in the biosimilar market: Evolution or revolution for generics companies?. http://www.ableindia.org/biosimilars.pdf
4. Barreda D Hanington P Belosevic M Regulation of myeloid development and function by colony stimulating factors Dev Comp Immunol 2004 28 509 554 10.1016/j.dci.2003.09.010 15062647
5. Wittman B Horan J Lyman GH: Prophylacti colony-stimulating factor in children receiving myelosupressive chemotherapy a meta-analysis of randomized controlled trials. Cancer Treat Rev 2006, 32:289-303. 10.1016/ j.ctrv.2006.03.002 16678350
6. Kuritzkes D Parenti D Ward D Rachlis A Wong R Mallon K Rich W Jacobson M: Filgrastim prevents severe neutropenia and reduces infective morbity in patients with advanced HIV infection: Results of a randomized, multicenter, controlled trial. Aids 1998, 12:65-74. 10.1097/ 00002030-199801000-00008 9456256
7. Babalola C Nightingale C Nicolau D: Adjunctive efficacy of granulocyte colony-stimulating factor on treatment of Pseudomonas aeruginosa pneumonia in neutropenic and non-neutropenic hosts. J Antimicrob Chemother 2004, 53:1098-100. 10.1093/jac/dkh237 15128727
8. Gough A Clapperton M Rolando N Foster A Howard J Edmonds M: Randomized placebo-controlled trial of granulocyte colony-stimulating factor in diabetic foot infection. The Lancet 1997, 350:855-859. 10.1016/ S0140-6736(97)04495-4
9. Harousseau JL Witz B Lioure B Berger M Desablens B Delain M Guilhot F Le Prise PY Abgrall JF Deconick E Guyotat D Vilque JP Casassus P Tournilhac O Audhuy B Solary E: Granulocyte colony-stimulating factor after intensive consolidation chemotherapy in acute myeloid leukemia: Results of a randomized trial of the group Ouest-Est leucémies aigues myeloblastiques. J Clin Oncol 2000, 18:780-787. 10673519
10. Carbonero R Mayordomo J Tornamira M Brea M Rueda A Guillem V Arcediano A Yubero A Ribera F Gomes C Tres A Peres-Gracia J Lumbreras R Hornedo J Funes H Paz-Ares L: Granulocyte colony-stimulating factor in the treatment of high-risk febrile neutropenia: A multicenter randomized trial. J Natl Cancer Inst 2001, 93:31-38. 10.1093/jnci/93.1.31 11136839
11. U.S Food & Drug Administration. U.S Department of Health and Human Services. Therapeutic Biological Products Approvals http://www.accessdata.fda.gov/scripts/cder/onctools/druglist.cfm
12. Nagata S Tsuchiya M Asano S Kaziro Y Yamazaki T Yamamoto O Hirata Y Kubota N Oheda M Nomura H Ono M: Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor. Nature 1986, 319:415-418. 10.1038/319415a0 3484805
13. Souza L: Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cell. Science 1986, 232:61-65. 10.1126/science.2420009 2420009
14. Lu S Boone T Souza L Lai P: Disulfide and secondary structure of recombinant human granulocyte colony-stimulating factor. Arch Biochem Biophys 1989, 1:81-92. 10.1016/0003-9861(89)90567-5
15. Oh-eda M Hasegawa M Hattori K Kuboniwa H Kojima T Orita T Tomonou K Yamazaki T Ochi N: O-linked sugar chain of human granulocyte colony-stimulating factor protects it against polymerization and denaturation allowing it to retain its biological activity. J Biol Chem 1990, 265:11432-11435. 1694845
16. Souza L: Production of pluripotent granulocyte colony-stimulating factor Patent US 4,810,643 1989
17. Boone T Miller Allan L Andresen Jeffrey W: Method for purifying granulocyte colony stimulating factor. Patent US 5,849,883 1998.
18. Porekar VG Menart V: Process for the purification and/or isolation of biologically active granulocyte colony stimulating factor Patent US 2005/ 01595589 2005
19. Sassenfeld H: Purification of G-CSF Patent US5,055,555 1991
20. Santos DS Chies JM Basso LA Renard G Fonseca IO: Method for the obtention of chimeric nucleotide sequences and chimeric nucleodite sequences. Patent application WO2007/068068 A2 2006
21. Jevsevar S Menart V: Synthetic gene coding for human granulocyte-colony stimulating factor for the expression in E coli. Patent US2006/0228781 2006
22. Jeong K Lee S: Secretory production of human granulocyte-colony stimulating factor in Eschericia coli. Protein Expr Purif 2001, 23:311-318. 10.1006/prep.2001.1508 11676607
23. Dubendorff JW Studier FW: Controlling basal expression in an inducible T7 expression system by blocking the target T7 promoter with lac repressor. J Mol Biol 1991, 219:45-59. 10.1016/0022-2836(91)90856-2 1902522
24. Grossman TH Kawasaki E Punreddy SR Osburne M: Spontaneous cAMP-dependent derepression of gene expression in stationary phase plays a role in recombinant expression instability. Gene 1998, 209:95-103. 10.1016/ S0378-1119(98)00020-1 9524234
25. Rizzi C Frazzon J Ely F Weber P Fonseca I Gallas M Oliveira J Mendes M Souza B Palma M Santos D Basso L: DAHP synthase from Mycobacteruim tuberculosis H37Rv: Cloning, expression, and purification of functional enzyme. Protein Expr Purif 2005, 40:23-30. 10.1016/j.pep.2004.06.040 15721768
26. Mendonça J Ely F Palma M Frazzon J Basso L Santos D: Functional characterization by genetic complementation of aroB-encoded dehydroquinate synthase from Mycobacteruim tuberculosis H37Rv and its heterologous expression and purification. J Bacteriol 2007, 189:6246-6252. 1951933 17586643 10.1128/JB.00425-07
27. Magalhaes M Pereira C Basso L Santos D: Cloning and expression of functional shikimate dehydrogenase (EC.1.1.25) from Mycobacterium tuberculosis H37Rv. Protein Expr Purif 2002, 29:59-64. 10.1016/ S1046-5928(02)00509-0
28. Venthanayagam JGG Flower AM: Decreased gene expression from T7 promoters may be due to impaired production of active T7 RNA polymerase. Microb Cell Fact 2005, 4:3. 545050 15638935 10.1186/1475-2859-4-3
29. Villaverde A Carrió MM: Protein aggregation in recombinant bacteria: Biological role of inclusion bodies. Biotechnol Lett 2003, 2:1385-1395. 10.1023/A:1025024104862
30. Choi J Keum K Lee S: Production of recombinant proteins by high cell density culture of Escherichia coli. Chemical Engineering Science 2006, 61:876-885. 10.1016/j.ces.2005.03.031
31. Clark E: Protein refolding for industrial process. Current Opinion in Biotechnology Engineering 2001, 12:202-207. 10.1016/S0958-1669(00)00200-7
32. Komath UD Lodha S Chigurupati J: Process for preparing G-CSF Patent WO2004/001056 2004
33. Codevilla C Brum L Oliveira P Dolman C Rafferty B Dalmora S: Validation of an SEC-HPLC method for the analysis of rhG-CSF in pharmaceutical formulation. Journal of liquid chromatography & related technologies 2004, 27:2681-2690.
34. Hammerling U Kroon R Sjodin L: In vitro bioassay with enhanced sensitivity for human granulocyte colony-stimulating factor. J Pharm Biomed Anal 1995, 13:9-20. 10.1016/0731-7085(94)00128-O 7536474
35. Bae CS Yang DS Chang KR Seong BL Lee J: Enhanced secretion of human granulocyte colony-stimulating factor directed by a novel hybrid fusion peptide from recombinant Saccharomyces cerevisiae at high cell concentration. Biotechnol Bioeng 1998, 57:600-609. 10.1002/ (SICI)1097-0290(19980305)57:5<600::AID-BIT12>3.0.CO;2-F 10099239
36. Manning M Patel K Borchardt R: Stability of protein pharmaceuticals. Pharm Res 1989, 6:903-918. 10.1023/A:1015929109894 2687836
37. Lu H Fausset P Narhi L Horan T Shinagawa K Shimamoto G Boone T: Chemical modification and site-directed mutagenesis of methionine residues in recombinant human granulocyte colony-stimulating factor: Effect on stability and biological activity. Arch Biochem Biophys 1999, 362:1-11. 10.1006/abbi.1998.1022 9917323
38. Massiero S: Study of chromatography methods for the potency evaluation of filgrastim and correlation with biological assay. Master's degree dissertation Federal University of Santa Maria, Brazil 2006
39. U.S Food & Drug Administration 2004N-0355: Scientific considerations related to developing follow-on protein products http://www.fda.gov/ ohrms/dockets/DOCKETS/04n0355/04n-0355-c000005-01-vol1.pdf
40. Pearlman R Wang J: Formulation, characterization, and stability of protein drugs. Pharmaceutical biotechnology. Plenum Press New York 1996, 9:303-325. 8914196
41. Finney JD: Statistical methods in biological assay. Charles Griffin London 1978
42. European Phamacopoeia Strasbourg: EDQM 4 2002
43. Laemmli U: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685. 10.1038/227680a0
44. Bradford MM Mcrorie RA Williams WL: A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254. 10.1016/ 0003-2697(76)90527-3 942051
45. Fonseca IO Magalhaes MLB Oliveira JS Silva RG Mendes MA Palma MS Santos DS Basso LA: Functional shikimate dehydrogenase from Mycobacterium tuberculosis H37Rv purification and characterization. Protein Expr Purif 2006, 46:429-437. 10.1016/j.pep.2005.10.004 16298142
46. Dalmora SL Massiero S Oliveira P Sangoi M Brum L: Validation of an RP-HPLC method and assessment of rhG-CSF in pharmaceutical formulation by liquid chromatography and biological assay. Journal of liquid chromatography & related technologies 2006, 29:1753-1767. 10.1080/ 10826070600716900
47. Gaines D Tydeman M: Iterative weighted regression analysis of logit responses. A computer program for the analysis of bioassay and immunoassays. Comput Programs Biomed 1980, 15:13-22. 10.1016/ 0010-468X(82)90052-6